Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Immunocore

Request full access

TCR bispecific immunotherapies for cancer and infectious diseases

Milton, United KingdomFounded 2008Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2021

Immunocore in the Milton ecosystem

Live from Dealroom

The Immunocore office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A3 investors entered at this stage

  • Eli Lilly
  • Woodford Investment Management
  • RTW Investments

Series B and later9 investors entered at this stage

  • JDRF T1D Fund
  • Rock Springs Capital
  • General Atlantic
  • WuXi Healthcare Ventures
  • BlackRock
  • Bill & Melinda Gates Foundation
  • CCB International
  • Omega Funds
  • University of Oxford
Employees mapped 607 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 5 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$101M

54 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Immunocore on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.